Name: INMB Balance Sheet - Inmune Bio Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

INMB - Inmune Bio, Inc.

USD | NASDAQ | Healthcare

INMB Balance Sheet - Inmune Bio Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash And Short Term Investments
Cash And Equivalents	24.8	20.9	35.8	52.2	74.8	22.0	7.0	0.2	1.4	0.1
Restricted Cash	-	-	-	-	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	24.8	20.9	35.8	52.2	74.8	22.0	7.0	0.2	1.4	0.1
Receivables
Accounts Receivable	4.3	1.2	1.9	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	0.6	0.3	1.5	4.0
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	0.1	-	-
Current Liabilities
Accounts Payable	-	-	-	-	-	-	-	-	-	-
Short Term Debt	-	-	9.9	5.0
Non-Current Liabilities
Long Term Debt	-	15.0	-	9.7	15.0	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.4	0.2	0.4
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-
Additional Paid In Capital	233.3	195.8	159.1	151.8
Supplementary Data
Total Debt	-	15.0	9.9	14.7	15.0	-	-	-	-	-
Net debt	-	(5.9)	(25.9)	(37.5)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q4 FY 16
Cash And Short Term Investments
Cash And Equivalents	-	-	27.7	33.4	19.3	20.9	33.6	31.1	26.0	35.8	41.8	47.8	51.0	52.2	57.4

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	0.7	0.6	0.5	0.5	0.2	0.3	0.9	1.0	1.1	1.5	1.5	2.7	0.0	4.0	4.6	4.2	4.7	2.3
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	22.8	29.9	30.7	36.0	21.0	22.7	35.9	35.5	29.8	39.9	45.6	52.6	56.9	64.7	66.7	70.5

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property,Plant & Equipment Net	0.9	1.0	0.9	0.7	-	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	16.5	16.5	16.5	16.5	16.5	16.5	16.5	16.5	16.5	16.5	16.5	16.5	16.5
Operating Lease Right Of Use Assets	1.4	0.9	1.1	0.4	0.3	0.3	0.3	0.4	0.4	0.4	0.4	0.5	0.5	0.5	0.5	0.7
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	0.7	0.6	0.7	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	25.8	32.4	33.4	37.7	37.8	39.6	52.8	52.5	46.8	57.0	62.7	69.7	74.0	81.8	83.8	87.8	94.4

Current Liabilities
Accounts Payable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Debt	-	-	-	-	-	-	2.5	5.0	7.5	9.9	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	0.7	0.6	0.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Accrued Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Liabilities	-	-	-	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.6	0.6	0.6	0.8	0.5	0.6
Total Current Liabilities	5.4	8.4	7.4	8.6	7.9	7.2	13.8	15.1	17.5	18.5	14.4	13.1	10.3	10.9	6.9	2.3

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-
Additional Paid In Capital	234.8	233.3	229.9	226.9	203.1	195.8	193.6	178.8	160.9	159.1	157.3	155.4	153.5	151.8	150.0	148.1	146.2
Retained Earnings	(214.4)	(209.0)	(203.8)	(197.3)	(172.8)	(163.1)	(153.9)	(141.8)	(132.0)	(121.0)	(112.6)	(104.1)	(97.6)	(91.0)	(85.2)	(77.5)	(70.6)
Accumulated Other Comprehensive Income	(0.7)	(0.7)	(0.8)	(0.8)	(0.6)	(0.6)	(1.0)	(0.7)	(0.7)	(0.8)	(0.7)	(0.7)	(0.7)	(0.7)	(1.1)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	19.6	23.5	25.4	28.9	29.7	32.1	38.7	36.3	28.2	37.3	43.9	50.7	55.3	60.1	63.7	69.9	75.6
Total Equity	19.6	23.5	25.4	28.9	29.7	32.1	38.7	36.3	28.2	37.3	43.9	50.7	55.3	60.1	63.7	69.9	75.6	80.2

Supplementary Data
Total Debt	-	-	-	15.0	15.0	-	2.5	5.0	7.5	9.9	12.5	15.0	15.0	-	15.0	15.0	15.0	15.0	15.0	15.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	(18.4)	(4.3)	-	(31.1)	(26.1)	(18.5)	(25.9)	(29.3)	(32.8)	(36.0)	-	(42.4)	(46.2)	(51.7)	(59.8)
Working Capital	17.4	21.5	23.3	27.4	13.0	15.4	22.0	20.4	12.4	21.5	31.3	39.6	46.6	53.8	59.8	68.3	73.8	78.2
Book Value	19.6	23.5	25.4	28.9	29.7	32.1	38.7	36.3	28.2	37.3	43.9	50.7	55.3	60.1	63.7	69.9	75.6	80.2
Tangible Book Value	-	-	-	-	13.2	15.6	22.2	19.8	11.7	20.8	27.4	34.1	38.8	43.6	47.2	53.4	59.1